Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)

Completed

Conditions studied: Small Cell Lung Cancer

In brief

The purpose of this study is to determine whether or not CTCs can be detected in blood samples taken from patients diagnosed with small cell lung cancer. The purpose is to compare CTC analysis to tumor samples to look for differences.

Key facts

Study ID

NCT01173458

Run by

University of Kansas Medical Center

People needed

25

Starts

2010-07-01

Expected to finish

2015-03-01

Last updated by the study team

2017-01-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histological proof of small cell lung cancer with extensive stage disease and have been untreated.
• Must be willing to give and sign informed consent.
• Must be 18 years of age

You may not qualify if…

• Less than 18 years of age.

Where it is running

• University of Kansas Medical Centner — Kansas City, Kansas, United States
• University of Nebraska & Omaha VA — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.